Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Almitrine mesylate (Almitrine dimesylate) inhibits selectively the Ca2+-dependent K+ channel and that in rat chemoreceptor cells,used in the treatment of hypoxemic chronic lung diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 35.00 | |
50 mg | In stock | $ 46.00 | |
100 mg | In stock | $ 78.00 | |
200 mg | In stock | $ 108.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 32.00 |
Description | Almitrine mesylate (Almitrine dimesylate) inhibits selectively the Ca2+-dependent K+ channel and that in rat chemoreceptor cells,used in the treatment of hypoxemic chronic lung diseases. |
In vivo | Almitrine dimesylate is a drug used in the treatment of hypoxemic chronic lung diseases such as bronchitis and emphysema because it is a potent stimulant of the carotid bodies in human and different animal species that produces a long-lasting enhancement of alveolar ventilation, ameliorating arterial blood gases[1]. |
Synonyms | Almitrine dimesylate, Almitrine bismethanesulfonate, Almitrine bismesylate |
Molecular Weight | 669.76 |
Formula | C28H37F2N7O6S2 |
CAS No. | 29608-49-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (186.63 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Almitrine mesylate 29608-49-9 Membrane transporter/Ion channel Potassium Channel inhibit Almitrine Dimesylate Almitrine dimesylate Almitrine bismethanesulfonate Inhibitor Almitrine Mesylate Almitrine bismesylate Almitrine KcsA inhibitor